首页> 外国专利> MULTIVALENT CD20 BINDING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT EFFECTOR REGIONS AND ENRICHED COMPOSITIONS THEREOF

MULTIVALENT CD20 BINDING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT EFFECTOR REGIONS AND ENRICHED COMPOSITIONS THEREOF

机译:包含志贺毒素亚单位区域的多价CD20结合分子及其丰富的组成

摘要

The present invention provides multivalent CD20 binding molecules and compositions thereof such as enriched compositions comprising large proportions of multivalent CD20 binding molecule relative to monovalent CD20 binding molecule. Certain multivalent CD20 binding molecules of the present invention comprise 1) two or more CD20 binding regions and 2) one or more Shiga toxin effector polypeptide regions derived from an A Subunit of a member of the Shiga toxin family. Certain multivalent CD20 binding molecules of the present invention and compositions thereof have uses for selective killing specific cell types and as therapeutics for the treatment of a variety of diseases including cancers tumors and immune disorders. Certain multivalent CD20 binding molecules of the present invention and compositions thereof have uses for delivering agents into CD20 expressing cells including for the intracellular labeling of CD20 expressing cells collecting diagnostic information and monitoring the treatment of variety diseases such as cancers tumors and immune disorders which involve CD20 expressing cells.
机译:本发明提供了多价CD20结合分子及其组合物,例如相对于单价CD20结合分子包含高比例的多价CD20结合分子的富集的组合物。本发明的某些多价CD20结合分子包含1)两个或多个CD20结合区和2)一个或多个衍生自志贺毒素家族成员的A亚基的志贺毒素效应物多肽区域。本发明的某些多价CD20结合分子及其组合物具有用于选择性杀死特定细胞类型的用途,以及用作治疗包括癌症,肿瘤和免疫疾病在内的多种疾病的治疗剂。本发明的某些多价CD20结合分子及其组合物具有用于将试剂递送到表达CD20的细胞中的用途,包括用于CD20表达细胞的细胞内标记,以收集诊断信息并监测多种疾病的治疗,例如涉及CD20的癌症,肿瘤和免疫疾病表达细胞。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号